Orchard Therapeutics ADR (NASDAQ:ORTX)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - ORTX
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ORTX
- Market Cap$581.610m
- SymbolNASDAQ:ORTX
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS68570P1012
Company Profile
Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.
Latest ORTX news
Currently there for this company. Visit our news hub for other news .